Crohn’s & Colitis Congress 2025 is in the books—and the revolutionary research and all the work being done behind the scenes for the IBD community are exhilarating and promising. Having been diagnosed with Crohn’s disease nearly 20 years ago, I had the opportunity to serve as a patient reporter ...

The Crohn’s & Colitis Foundation recently announced our new five-year research agenda following a year-long process where we brought together researchers, clinicians, patients, and caregivers to identify the most pressing priorities for the IBD research community. Our research agenda is publishe...

 In 2016, during an interview with the Crohn’s & Colitis Foundation, then Chief Scientific Officer Caren Heller, MD, asked Andrés Hurtado-Lorenzo, PhD, now Senior Vice President of Translational Research & IBD Ventures, a pivotal question: “What would you do to make the Crohn’s & Co...

In the world of healthcare and research, there are individuals who stand out as true pioneers, disruptors, and visionaries. Caren Heller, MD, MBA, Chief Scientific Officer of the Crohn's & Colitis Foundation, is undoubtedly one of them.   With extensive experience in the pharmaceu...